Based
BOSTON, MASSACHUSETTS
BOSTON, MASSACHUSETTS
Year formed
2023
2023
Industry group
Biotechnology
Biotechnology
Filings
4
4
Raised (new offerings)
$70.48M
$70.48M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-09-03 | New offering first sale 2026-08-10 | $65.48M | $65.48M | details · SEC filing |
| 2025-08-26 | New offering first sale 2025-08-14 | $5M | $5M | SEC filing |
| 2024-09-04 | Filing | — | — | SEC filing |
| 2023-08-28 | Filing | — | — | SEC filing |
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Superluminal Medicines, Inc.'s own filings with the SEC. The people those filings name are on the team page.